Advanced search

Mr. Mathieu O. Floreani is a Chairman-Management Board & CEO at Synlab AG, a Co-Managing Director at LS Medizin Service GmbH, a Group Chief Executive Officer at SYNLAB International GmbH and a Co-Managing Director at Medizinisches Versorgungszentrum SYNLAB Leverkusen GmbH. He is on the Board of Directors at Synlab Diagnósticos Globales SA, ALcontrol Group Ltd., Labco UK Group Ltd. and SYNLAB Ltd. Mr. Floreani was previously employed as a President, Chief Executive Officer & Director by DHL Global Forwarding North America and a Managing Director by SYNLAB Medizinisches Versorgungszentrum Stuttgart GmbH.

Mr. Mathieu Bonnet is a Chairman at E6 SAS, a Chief Executive Officer & Director at Allego BV, a Chief Executive Officer & Director at Allego NV, a Chief Executive Officer at Allego BV (New) and a President at Spartan Acquisition Corp.
III.
He is on the Board of Directors at Allego BV and Allego NV.
Mr. Bonnet was previously employed as a Chief Executive Officer by Compagnie Nationale du Rhône.
He received his undergraduate degree from Ecole Polytechnique, a graduate degree from École Nationale Supérieure des Mines de Paris and a graduate degree from Université Catholique de Louvain.

Mathieu Lamy occupies the position of Chief Operating Officer & Executive Vice President at Intact Financial Corp. He is also Senior Vice President-Claims at Claims At Intact Insurance. He previously was Chief Information Officer & Senior Vice President for IntAct Labs LLC, Executive Vice President-Operations for AXA Life Insurance (Canada) and Executive Vice President of AXA Canada, Inc. Mr. Lamy received an undergraduate degree from Université Laval.

Mathieu Bernard Streiff is the founder of American Healthcare Investors LLC, which was founded in 2011.
He held the title of General Counsel & Managing Director at the firm from 2011 to 2019.
Mr. Streiff's current jobs include being a Director at Hawkhill House Ltd.
since 2016, a Director at American Healthcare REIT, Inc. since 2015, a Director at GAHC3 U.K.
Senior Care Holding Ltd., a Director at Coniston Care Centre Ltd.
since 2016, a Director at Orchard St Albans Housing Portfolio Ltd.
since 2015, a Member of the New York State Bar Association, an Executive Vice President at Griffin-American Healthcare REIT Sub-Advisor, LLC since 2012, and an Executive Vice President at Griffin-American Healthcare REIT III Advisor LLC since 2012.
Mr. Streiff's former jobs include being a Director at Trilogy Investors LLC, Executive Vice President & General Counsel at Grubb & Ellis Co. from 2010 to 2011, Executive Vice President & General Counsel at Griffin-American Healthcare REIT II, Inc. from 2012 to 2014, Executive Vice President & General Counsel at Griffin-American Healthcare REIT III, Inc. from 2013 to 2021, an Associate at Latham & Watkins LLP from 2002 to 2006, Secretary, Executive VP & General Counsel at Grubb & Ellis Realty Investors LLC in 2011, and Executive Vice President at Griffin American Healthcare Reit Advisor LLC from 2011 to 2014.
Mr. Streiff's education includes an undergraduate degree from the University of California, Berkeley and a graduate degree from Columbia Law School.

Dr. Mathieu Simon is a Chairman at Epsilen Bio SRL, a Chairman at Idorsia Ltd., an Independent Director at Asarina Pharma AB, an Independent Director at Vaximm AG, a Chairman at Idorsia Pharmaceuticals Ltd., a Chief Executive Officer at Cellectis Therapeutics and an Independent Director at LNC Therapeutics SA. He is on the Board of Directors at Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associés SCA and LNC Therapeutics SA. Dr. Simon was previously employed as an EVP, Chief Operating & Medical Officer by Cellectis SA, a Vice President-Marketing & Medical Affairs by Wyeth Pharmaceuticals LLC, a Group VP-Marketing & Clinical Affairs by Wyeth-Ayerst International, Inc., a Senior Vice President-Global Operations by Pierre Fabre Médicament SAS, a Managing Director & Head-Global Pharma by Pierre Fabre SA, and a Chairman & Chief Executive Officer by Takara Bio Europe AB. He also served on the board at Alliance for Regenerative Medicine, Ectycell SASU and Farmindustria.

Currently, Mathieu Vrijsen occupies the position of Chairman-Supervisory Board at Casco Phil, Chairman-Supervisory Board for Broadview Holding BV and Chairman-Supervisory Board of Corbion NV. Mr. Vrijsen is also on the board of Swiss-American Chamber of Commerce, The European Association for Bioindustries, Desso BV and Joma Sport BVBA and Member-Executive Committee at International Institute for Management Development. In his past career he held the position of Senior Vice President-Operations & Engineering at E.I. du Pont de Nemours & Co.

Mr. Patrick Floreani, CFA MBA, is a Managing Director & Portfolio Manager at WealthBridge Investment Counsel, Inc. He is a co-founder of WealthBridge and has been involved in the financial services industry since the mid-1990s.
His primary duty is to run and manage WealthBridge Investment Counsel Inc., the discretionary portfolio management arm of WealthBridge.
As Portfolio Manager, he steers the overall development and implementation of investment strategy for all clients.
He is also primarily responsible for the equity portion of client portfolios.
His career started in the early 1990s where he was employed with Canada Revenue Agency in various capacities.
In 1996 he joined CWM Investment Counsel Inc. as a Portfolio Manager.
In 2002, he was made a Partner in Canadian Wealth Management Group (CWM), while continuing his role as Portfolio Manager.
In 2008 CWM was sold to Société Générale (SG), at which point he became Chief Investment Officer of CWM Investment Counsel Inc. as well as CWM Funds Inc., and was responsible for overseeing the management of over $600 Million in client assets.
He was also part of the SG Global Investment Committee and provided the North American perspective to the team.
He is a graduate of the University of Alberta.
After graduating with a Bachelor of Science degree (specialization in Genetics), he then obtained his Master of Business Administration (MBA) degree, also from the University of Alberta (concentration in Finance).
He obtained his Chartered Financial Analyst (CFA) charter in 1998.

Martin E.
Floreani is currently the President & Chief Executive Officer at French Transit LLC since 2017.
Previously, he worked as the Regional Marketing Manager at Merck & Co., Inc., Vice President-Global Strategy at Stiefel Laboratories, Inc., VP-International Sales & Market Development at Advanced Bio-Technologies, Inc., and Chief Marketing Officer & EVP-International at Enaltus LLC.
Mr. Floreani completed his undergraduate and MBA degrees from Miami University.

Zaz Floreani is currently a Partner at Firstmile Ventures LLC.
Previously, Zaz held positions as Director-Business Development at AVP Management Services, Inc., Principal at Genesis Global Trading, Inc., and Principal at Next Coast Ventures LLC.
Zaz has an undergraduate degree from the University of California, Los Angeles, and graduate degrees, including an MBA, from The University of Texas at Austin and McCombs School of Business.

Martin Floreani founded FloSports, Inc. in 2006 and held the titles of President, Chief Executive Officer & Director.
Mr. Floreani is also the founder of Rokfin, Inc.

Mark Floreani is the founder of FloSports, Inc. He is currently serving as the Chief Executive Officer & Director of the company, which was founded in 2006.

Mathieu currently works at Tours Amérique, Inc., as Director General.

Mathieu Quéré is currently the Chairman of Maremma SASU since 2013.
He was previously the Chairman-Management Board of Buffalo Grill SAS from 2014 to 2018 and the Managing Director of Abénex Capital SAS from 2010 to 2012.
He also worked as a Manager at Bain & Co., Inc. Mr. Quéré completed his undergraduate degree at ESSEC Business School and his graduate degree at Université de Versailles Saint-Quentin-en-Yvelines.

Pascal Mathieu is currently working as a Manager at Société de Bourse Gilbert Dupont SNC.
Previously, he held the position of Chairman-Executive Board at Natixis Securities SA and Head of Research-Mid Caps Europe at Exane SA (Broker).

Mr. Mathieu Picard is an Absolute Return Manager at DNCA Finance SA. He joined the DNCA Finance Absolute return team in September 2009.
In 2002, Mr. Picard became a sell-side financial analyst at IXIS Securities.
In June 2006, he moved to the proprietary management team as a financial analyst at IXIS CIB, which became NATIXIS.
He holds a postgraduate degree in Finance from Sciences-Po Paris and a master’s degree from Paris IX Dauphine University.

Mathieu Bigois has been Vice President of Finance and Business Development for DrugAbuse Pharmaceutical, Inc. since September, 2003.
Prior to joining DrugAbuse Pharmaceutical, he was Director of Finance for DrugAbuse Sciences SAS.
Previously, Mr. Bigois worked at Wasserstein Perella & Co. and Credit Suisse First Boston.
He received an undergraduate degree from Ecole Centrale Paris and an MS degree in Finance and Economics from the University of London.

Mr. Mathieu Nègre, CFA, is an Investment Manager at Union Bancaire Privée, UBP SA. He is also a Head of Emerging Equities and lead manager of the Global Emerging Equities strategy.
He has been covering emerging equities since 2001.
Mr. Nègre holds a postgraduate degree in statistics from ENSAE in France and has been a CFA charter holder since 2006.

Mathieu Senard is associated with Alter Eco Americas, Inc. as the founder.
He held the position of Co-Chief Executive Officer from 2013 to 2018.
Alter Eco Americas, Inc. was founded in 2004.

Mathieu Kerneis has worked at AXA Investment Managers (Paris) SA since 2010.
His current position is Head of Wholesale, which he started in 2021.

Mathieu Lavoie is the founder.
He founded Flare Systems, Inc. in 2017 and holds the title of Chief Technology Officer.
Currently, Mr. Lavoie is a Member at Ordre des Ingénieurs du Québec.
In the past, he worked as the Vice President-Operations at Junex, Inc. Mr. Lavoie completed his undergraduate degree at Université Laval.

Mathieu Bourdié is currently the CFO at ODDO BHF Private Equity SA, the Controller at Exmer SL, and the CFO & Head of Investor Relations at C4 Ventures.
Previously, he worked as an Executive Director at Altamar CAM Partners SL and as a Controller at Mercapital Private Equity SGECR SA. Bourdié received a graduate degree from Instituto de Empresa SL in 1999 and another graduate degree from Université Paris Dauphine-PSL in 2000.

Mr. Lane joined SR One in 2009.
He has extensive experience with the pharmaceutical industry including 7 years in Bear Stearns' Health Care investment banking group.
He has been involved in the execution of transactions for companies such as Amgen, Schering Plough, Amylin, Celgene, ZymoGenetics, Myriad Genetics, Idenix, Cypress Bioscience, Par Pharmaceuticals, Synta and Archemix.
Prior to Bear Stearns, Mr. Lane worked for 6 years as an organic chemist at Genzyme.
Mr. Lane received a Bachelor's Degree in Chemistry from Vassar College and an MBA in Finance and Accounting from NYU.

Romen Joseph Mathieu is currently the Chairman & Chief Executive Officer at Khoury Home Appliances SAL, an Independent Director at Chedid Capital SAL (Holding), a Non-Executive Director at SEIB Insurance & Reinsurance Co. LLC, and the Managing Partner at The EuroMena Funds since 2004.
He previously worked as a Director at Palestine Securities Exchange Public Shareholding Co. Ltd.
in 2010.
Mr. Mathieu is a graduate of Sorbonne Université.

Mathieu Guay is currently working as a Geology Manager at Vior, Inc. and as a Member at Ordre des Géologues du Québec.
Previously, he worked as a Senior Geologist at Adventure Gold, Inc. He completed his undergraduate degree at Université du Québec à Chicoutimi.

Mathieu Omnes currently works at Diagnostic Medical Systems, as Investor Relations Officer, Auplata Mining Group SA, as Investor Relations Officer, and Gold by Gold SA, as Head-Investor & Press Relations.

Mathieu Azzouz is currently the Head of Impact Investing at Amundi Asset Management SA (Investment Management).
Previously, he worked as a Portfolio Manager at Integral Development Asset Management SA.

Mathieu Neirinck is currently the Department Head of Commercial Banking Strategy at KBC Asset Management NV.
Previously, he worked as a Sales Associate at Banque Degroof Petercam SA (Broker).

Patrick Mathieu is currently the Chief Executive Officer at Armacell LLC and Armacell International SA. He is also a Director at Ultima Holding Ltd., TERREAL SASU, Armacell Enterprise GmbH & Co. KG, and Ultima Acquisition GB Ltd.
In the past, he worked as the Director-Western Europe Region at Saint-Gobain Corp., Director at Terreal Holding SAS and Tarkett Ltd., and Technical Director at Weber Group LLC.
He completed his undergraduate degree at the University of Orléans.

Mathieu Charette is a professional who currently works as a Member at Ordre des comptables professionnels agréés du Québec since 2006.
He previously worked as CFO, Director & Secretary at WAI Capital Investments Corp.
from 2011 to 2016.
He also held positions as Controller at GoviEx Uranium, Inc. and Quebecor World Vancouver.
Additionally, he worked as Vice President-Finance & Controller at SRG Mining, Inc. Mr. Charette obtained his undergraduate degree from HEC Montréal in 2004.

Mr. Mathieu Lachance, CFA, is a Portfolio Manager at Crystalline Management, Inc. He joined the firm in July 2012.
After he begun his career as fixed income and currency derivatives arbitrage trader at the Quebec Ministry of Finance as well at PSP Investments, he was recruited in 2009 by Natcan as Vice President Fixed Income, responsible for various mandates including international (G7) instruments, structured (mortgage-backed) products, and numerous credit instruments.
He obtained his CFA and DMS designations, and completed his MSc in 2005 in Finance from the University of Sherbrooke, where he has been a lecturer in the Department of Finance since 2006.

Mathieu Marc has worked as a Deputy Director at Siparex XAnge Venture SAS since 2015.

Mr. Yannick Mathieu is Partner at Coral Reef Capital Group LLC.
Prior to Coral Reef, he was part of the senior management team of Citadel Investment Group for three years where he was Chief of Staff of the Management Committee.
He was also Chief Operating Officer of the credit businesses at Citadel, where he was responsible for organizing the teams in high yield, distressed debt, convertible bonds, mortgage and structured products.
Prior to joining Citadel, Mr. Mathieu was management consultant for McKinsey & Company in New York for five years.
Prior to McKinsey, he was product manager for Rhone Poulenc based in Tokyo, covering Asia-Pacific, for four years.
Mr. Mathieu graduated with a MBA in Finance and Entrepreneurial Management from the Wharton School at the University of Pennsylvania and a Masters of Science from the University of Illinois at Urbana-Champaign and from Ecole des Mines in Nancy, France.

Mathieu Piché is currently an Independent Director at Q Battery Metals Corp.
and Rocket Gold Corp.
He is also a Member of the Ordre des Géologues du Québec.
Previously, he worked as a Senior Geologist at Pershimco Resources, Inc. Dr. Piché completed his undergraduate degree at the University of Montréal in 1981.
He then pursued a graduate degree at Université du Québec à Chicoutimi in 1986, followed by a doctorate degree from the same institution in 1991.

Mathieu Chabert is currently a Portfolio Manager at Point72 France SASU since 2022.
Prior to this, he worked as an Analyst at Exane Asset Management SA from 2014 to 2021 and as a Research Analyst at Bryan, Garnier & Co Ltd.
(France) from 2011 to 2014.